Howe & Rusling Inc Organon & Co. Transaction History

Howe & Rusling Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $397 - $582	17 Added 17.71%	113 $3,000
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $1,552 - $2,007	-51 Reduced 34.69%	96 $3,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $458 - $594	-16 Reduced 9.82%	147 $4,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $13,513 - $16,822	-472 Reduced 74.33%	163 $5,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $18,065 - $24,130	635 New	635 $19,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.